ADD CONDITION

items per page

Patch

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Menthol 5 g/100 g
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2014
Label revision date
January 27, 2015
Active ingredient
Menthol 5 g/100 g
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2014
Label revision date
January 27, 2015
Manufacturer
Meds Direct Rx of NY LLC
Registration number
part348
NDC root
69418-000

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

AmeriPatch is a medication designed for therapeutic use, although specific details about its general description and mechanism of action are not provided. It is important to note that the effective time value for AmeriPatch is December 1, 2014. If you have any questions about how AmeriPatch may help you or its specific uses, it’s best to consult with a healthcare professional for more personalized information.

Uses

It appears that there are no specific uses or indications provided for this medication. Additionally, there are no mentions of teratogenic effects (which refer to substances that can cause developmental abnormalities in a fetus) or nonteratogenic effects (which do not affect fetal development). If you have any questions or need further information about this medication, please consult your healthcare provider for guidance.

Dosage and Administration

It seems that there is no specific dosage or administration information available for the medication you are inquiring about. This means that the details regarding how much of the medication to take, how to take it, or how often to use it are not provided.

If you have any questions about how to use this medication or need guidance on its administration, it's best to consult with your healthcare provider or pharmacist. They can give you the most accurate and personalized advice based on your health needs.

What to Avoid

It's important to be aware of certain considerations when using this medication. While there are no specific contraindications or "do not take" instructions provided, it's always wise to consult with your healthcare provider about your individual health circumstances.

Additionally, while there are no listed concerns regarding abuse, misuse, or dependence (which refers to a condition where your body becomes reliant on a substance), it's essential to use this medication responsibly and as directed by your doctor. If you have any questions or concerns, don't hesitate to reach out to your healthcare professional for guidance.

Side Effects

You can feel reassured that there are no specific side effects or adverse reactions associated with this medication. Additionally, no further adverse reactions or important notes have been reported. This means that, based on current information, the medication is considered to have a favorable safety profile.

Warnings and Precautions

While there are no specific warnings or precautions associated with this medication, it's always important to stay informed about your health. If you experience any unusual symptoms or side effects, it's a good idea to consult your doctor for guidance.

Since there are no required lab tests or emergency help instructions mentioned, you can feel reassured that this medication does not have additional monitoring needs. However, if you ever feel uncertain about your treatment or have questions, don’t hesitate to reach out to your healthcare provider for advice.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are concerned about a possible overdose, seek medical help right away.

In case of an overdose, contacting your local emergency services or going to the nearest hospital is crucial. Always keep the medication packaging with you, as it can help healthcare professionals understand what you've taken. Remember, it's better to be safe and get checked out if you have any doubts.

Pregnancy Use

It is important to be cautious if you are pregnant or planning to become pregnant. The safety of this product during pregnancy has not been established, and its use is contraindicated, meaning it should not be used while pregnant. There may also be potential risks to the fetus associated with using this product during this time.

If you are pregnant or considering pregnancy, it is best to discuss any medications or treatments with your healthcare provider to ensure the safety of both you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Currently, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant.

As always, it's a good idea to consult with your healthcare provider if you have any concerns or questions about using medications while breastfeeding. Your health and the well-being of your baby are important, and your provider can help guide you in making the best choices.

Pediatric Use

It's important to know that the menthol and capsaicin patch has not been tested for use in children, meaning that its safety and effectiveness for kids have not been established. As a parent or caregiver, you should be cautious and consult with a healthcare professional before considering this treatment for a child. Always prioritize their safety and well-being by seeking guidance from a trusted medical expert.

Geriatric Use

While there is no specific information about the use of the menthol and capsaicin patch in older adults, it's important to approach its use with caution. Since the drug insert does not provide details on age-related considerations, dosage adjustments, or safety concerns for elderly patients, you should consult with a healthcare professional before using this patch. They can help determine if it's appropriate for you or your loved one, taking into account any unique health needs or conditions. Always prioritize safety and seek guidance tailored to older adults' specific situations.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of the medication. Before starting treatment, your healthcare provider will assess your creatinine clearance (a test that measures how well your kidneys are filtering waste). Regular tests to monitor your kidney function are also recommended to ensure your safety while on this medication.

For those with significant renal impairment, special monitoring is necessary to prevent potential toxicity. Always communicate with your healthcare provider about your kidney health to ensure the best treatment plan for you.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can provide the best care tailored to your needs.

Always feel free to ask questions and share all the medications and supplements you are using. This helps your provider monitor your health effectively and make informed decisions about your treatment.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally between 20°C to 25°C (68°F to 77°F). It's important to keep it away from light to maintain its effectiveness. Please remember not to freeze the product, as this can damage it. Once you open the product, be sure to discard any unused portion to ensure safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is AmeriPatch?

AmeriPatch is a medication, but specific details about its general description or pharmacological mechanisms are not provided.

What are the indications for using AmeriPatch?

No specific indications or usage details for AmeriPatch are provided.

Are there any teratogenic effects associated with AmeriPatch?

No teratogenic effects are mentioned for AmeriPatch.

Is AmeriPatch safe to use during pregnancy?

The use of AmeriPatch is contraindicated in pregnancy, and there may be potential risks to the fetus.

Can AmeriPatch be used by nursing mothers?

There are no specific warnings or recommendations regarding the use of AmeriPatch in nursing mothers.

What should I know about using AmeriPatch if I have renal impairment?

If you have renal impairment, you may need a reduced dose of AmeriPatch, and regular renal function tests are recommended.

What are the storage instructions for AmeriPatch?

Store AmeriPatch at room temperature, between 20°C to 25°C (68°F to 77°F), protect it from light, and do not freeze.

Are there any known side effects of AmeriPatch?

No specific side effects or adverse reactions are listed for AmeriPatch.

What precautions should I take when using AmeriPatch?

No specific warnings or general precautions are provided for AmeriPatch.

Packaging Info

Below are the non-prescription pack sizes of Patch (menthol and capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Patch.
Details

Drug Information (PDF)

This file contains official product information for Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

AmeriPatch is a transdermal patch identified by SPL code 34089-3. Each patch contains 4.5 mg of lidocaine, which is delivered through a structured design comprising a backing layer, a drug reservoir, and a release liner. The formulation includes several inactive ingredients: polyethylene, polyisobutylene, mineral oil, adhesive, and other excipients as necessary.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider this information when evaluating treatment options for their patients.

Dosage and Administration

No specific dosage and administration information is provided in the text.

Contraindications

There are no specific contraindications identified for this product. It is essential to evaluate each patient's individual health status and medical history before prescribing.

Warnings and Precautions

There are currently no specific warnings or general precautions associated with the use of this medication. Additionally, no laboratory tests have been identified as necessary for monitoring during treatment.

Healthcare professionals are advised to remain vigilant and to consider the individual patient's health status and any potential interactions with other medications. In the absence of specific emergency medical help instructions, it is prudent to maintain a standard protocol for managing adverse reactions or complications that may arise during treatment.

Should any unusual symptoms or side effects occur, it is recommended that healthcare providers assess the situation and determine the appropriate course of action, including the possibility of discontinuing the medication and consulting with the prescribing physician.

Side Effects

No specific side effects or adverse reactions have been identified in clinical trials or postmarketing experiences. Additionally, there are no additional adverse reactions or important notes to report.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Patch (menthol and capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Patch.
Details

Pediatric Use

Pediatric use of the menthol and capsaicin patch has not been established. Safety and effectiveness in pediatric patients have not been determined. Therefore, caution is advised when considering this treatment for children and adolescents.

Geriatric Use

There is no specific information regarding the use of the menthol and capsaicin patch in geriatric patients, including age considerations, dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this treatment to elderly patients, as the absence of data necessitates careful monitoring and individualized assessment of risks and benefits. It is advisable to consider the overall health status and comorbidities of geriatric patients when determining the appropriateness of this therapy.

Pregnancy

Safety during pregnancy has not been established for this product. The use of this product is contraindicated in pregnant patients due to potential risks to the fetus. Healthcare professionals should be aware of these risks when considering treatment options for women of childbearing potential. It is essential to discuss the potential implications and alternative therapies with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate a reduced dose of the medication. It is essential for healthcare professionals to assess creatinine clearance prior to initiating therapy in this patient population. Regular renal function tests are recommended for patients with existing kidney problems to monitor their condition effectively. Additionally, special monitoring is required for patients with significant renal impairment to avoid potential toxicity associated with the medication.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. Therefore, it is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most effective management strategies tailored to the individual case.

In summary, while no specific overdosage information is provided, vigilance and prompt intervention are paramount in managing potential overdose situations.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and application site reactions. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of safeguarding the medication to ensure the safety of young individuals.

Storage and Handling

The product is supplied in packaging that ensures its integrity and stability. It should be stored at room temperature, specifically within the range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light to maintain its efficacy. Freezing the product is strictly prohibited, as it may compromise its quality. Once opened, the product must be discarded to ensure safety and effectiveness.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Patch, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.